PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors

NCT00023855 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: bortezomib
DRUG: doxorubicin hydrochloride

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]